{
  "source": "Mifeprex-Benefit-Determination.txt",
  "chunks": [
    "UnitedHealthcare Pharmacy\nClinical Pharmacy Programs\nProgram Number 2025 P 4019-4\nProgram Benefit Determination –Mifeprex 200 mg and mifepristone (generic\nMifeprex) 200 mg\nMedication Mifeprex 200 mg and mifepristone (generic Mifeprex) 200 mg\nP&T Approval Date 11/2022, 1/2023, 3/2024, 4/2025\nEffective Date 7/1/2025\n1. Background:\nEffective January 3, 2023, the Risk Evaluation and Mitigation Strategy (REMS) program for\nMifeprex (mifepristone) was revised to allow the product to be dispensed by certified retail and\nmail order pharmacies. Previously, this product was only available when ordered, prescribed, and\ndispensed by or under the supervision of a healthcare provider.\nThese products are standardly covered without prior authorization. The purpose of this program is\nto determine coverage of Mifeprex 200 mg and mifepristone (generic Mifeprex) 200 mg when\nvariations to our standard are present in plan benefit documents (e.g., required by state mandate,\ngroup choice, etc.).\n2. Coverage Criteria:\nA. Authorization\n1. Mifeprex 200 mg and mifepristone (generic Mifeprex) 200 mg will be approved\nbased on the following criterion:\na. Treatment is required consistent with services covered by the patient’s medical\nbenefit plan. (For more information about covered and excluded termination of\npregnancy services, providers may review the patient’s medical benefit plan\ndocument or access information contained in the member’s medical benefit plan\ndocument, by contacting provider services at 1-888-842-3210, or accessing the\nprovider portal at www.uhcprovider.com)\nAuthorization will be issued for 1 month.\n3. Additional Clinical Rules:\n• Notwithstanding Coverage Criteria, UnitedHealthcare may approve initial and re-authorization\nbased solely on previous claim/medication history, diagnosis codes (ICD-10) and/or claim logic.\nUse of automated approval and re-approval processes varies by program and/or therapeutic class.\n4. References:\nN/A\n© 2025 UnitedHealthcare Services Inc.\n1\nProgram Ben",
    "odes (ICD-10) and/or claim logic.\nUse of automated approval and re-approval processes varies by program and/or therapeutic class.\n4. References:\nN/A\n© 2025 UnitedHealthcare Services Inc.\n1\nProgram Benefit Determination – Mifeprex 200 mg and mifepristone (generic\nMifeprex) 200 mg\nChange Control\nDate Change\n11/2022 New program.\n1/2023 Updated background and criteria to refer to medical plan documents.\n2/2024 Annual review. No updates.\n4/2025 Annual review. No updates.\n© 2025 UnitedHealthcare Services Inc.\n2"
  ]
}